# Centene Corp: Form 10-Q for the period ended Sep 30, 2021

- Company: [Centene Corp](/companies/cnc.md) (CIK 1071739)
- Form: 10-Q
- Filed: 2021-10-26
- Accepted by EDGAR: Oct 26, 2021, 00:48 ET
- Period: 2021-09-30
- Accession: 0001071739-21-000226
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1071739/000107173921000226/cnc-20210930.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1071739/000107173921000226/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2021-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2021-07-01 to 2021-09-30 | $30.51bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months, 2021-01-01 to 2021-09-30 | $87.49bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2021-07-01 to 2021-09-30 | $1.35bn | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months, 2021-01-01 to 2021-09-30 | $3.51bn | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 3 months, 2021-07-01 to 2021-09-30 | $2.68bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2021-01-01 to 2021-09-30 | $7.32bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2021-07-01 to 2021-09-30 | $545.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2021-01-01 to 2021-09-30 | $1.18bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2021-07-01 to 2021-09-30 | $170.0m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2021-01-01 to 2021-09-30 | $503.0m | us-gaap:InterestExpense |
| Income tax | 3 months, 2021-07-01 to 2021-09-30 | $139.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2021-01-01 to 2021-09-30 | $376.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2021-07-01 to 2021-09-30 | $584.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2021-01-01 to 2021-09-30 | $748.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2021-07-01 to 2021-09-30 | $0.99 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2021-01-01 to 2021-09-30 | $1.27 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2021-07-01 to 2021-09-30 | $1.00 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2021-01-01 to 2021-09-30 | $1.28 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2021-07-01 to 2021-09-30 | 590,702,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2021-01-01 to 2021-09-30 | 590,154,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2021-01-01 to 2021-09-30 | $3.53bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2021-01-01 to 2021-09-30 | $662.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 9 months, 2021-01-01 to 2021-09-30 | $49.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2021-09-30 | $13.42bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2021-09-30 | $28.06bn | us-gaap:AssetsCurrent |
| Total assets | at 2021-09-30 | $77.74bn | us-gaap:Assets |
| Current liabilities | at 2021-09-30 | $25.04bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2021-09-30 | $51.07bn | us-gaap:Liabilities |
| Long-term debt | at 2021-09-30 | $18.59bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2021-09-30 | $245.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2021-09-30 | $26.47bn | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1071739/000107173921000226/cnc-20210930.htm

Filed Oct 26, 2021.
Source: SEC EDGAR, the filing index for accession 0001071739-21-000226. Last ingested by Listed: Oct 24, 2026, 15:03 ET. No prices; not investment advice.
